XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating activities:    
Net loss $ (894,040) $ (53,799)
Adjustments to reconcile net loss to cash provided by operating activities:    
Depreciation and amortization 120,552 137,974
Goodwill impairment charge 106,389 0
Loss on classification to held for sale 649,140 0
Share-based compensation expense 14,989 13,601
Deferred income tax benefit (12,308) (9,029)
Changes in operating lease right-of-use assets and lease liabilities 14,411 3,766
Gain from sale and dispositions of patient service equipment and other fixed assets (9,322) (27,876)
Changes in operating assets and liabilities:    
Accounts receivable, net 141,875 (68,118)
Inventories (155,576) (123,077)
Accounts payable 145,324 203,371
Net change in other assets and liabilities (124,712) (19,517)
Other, net 5,822 5,891
Cash provided by operating activities 2,544 63,187
Investing activities:    
Additions to patient service equipment and other fixed assets (123,576) (90,379)
Proceeds from sale of patient service equipment and other fixed assets 35,004 67,026
Additions to computer software (10,635) (4,829)
Other, net (1,910) (8,858)
Cash used for investing activities (101,117) (37,040)
Financing activities:    
Borrowings under amended Receivables Financing Agreement 0 667,300
Repayments under amended Receivables Financing Agreement 0 (667,300)
Borrowings under Revolving Credit Facility 1,630,184 0
Repayments under Revolving Credit Facility (1,495,184) 0
Repayments of debt 0 (12,375)
Repurchase of common stock (6,656) 0
Other, net (3,867) (12,545)
Cash provided by (used for) financing activities 124,477 (24,920)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 1,801 (682)
Net increase in cash, cash equivalents and restricted cash 27,705 545
Cash, cash equivalents and restricted cash at beginning of period 49,382  
Cash, cash equivalents and restricted cash at end of period 77,087  
Cash, cash equivalents and restricted cash at beginning of period 27,572 272,924
Cash, cash equivalents and restricted cash at end of period 38,258 273,469
Supplemental disclosure of cash flow information:    
Income taxes paid, net 5,458 5,240
Interest paid 65,845 70,819
Noncash investing activity:    
Unpaid purchases of patient service equipment and other fixed assets at end of period $ 73,437 $ 76,373